Project Description
Follow-On Offering
Common Stock
.
$21,800,000
Co-Manager
February 2020
EyePoint PharmaceuticalsDaniel Malowany2020-06-25T10:48:05-04:00
Follow-On Offering
Common Stock
.
$21,800,000
Co-Manager
February 2020